https://clinicaltrials.gov/ct2/show/NCT04072887?type=Intr&cond=COPD&sfpd_d=14&sel_rss=new14 Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients Condition : Pulmonary Disease, Chronic Obstructive Interventions : Drug: QBW251; Drug: Placebo Sponsor : Novartis Pharmaceuticals Not yet recruiting NCT04072887 Wed, 28 Aug 2019 12:00:00 EDT
